Please select the title of the trial for more information.
| Title: |
Purpose: |
| Abbott
Xience |
Cardiac Stent Study (post market stent) |
| Aristotle |
Atrial Fibrillation |
| Improve
It |
Acute Coronary Syndrome |
| Precision |
Osteoarthritis/Rheumatoid Arthritis in Cardiac Patients |
| Trilogy |
Acute Coronary Syndrome |
| Abbott Spirit |
Trial of the XIENCE V® Everolimus Eluting Coronary Stent System |
| CV
Therapeutics |
Responsiveness of a New Female-Specific Angina
Questionnaire |
| Medtronic
SLS |
Monitor the long-term function of Medtronic heart-related
products |
| Platinum |
The PROMUS Element™ Everolimus-Eluting
Coronary Stent System |
| Roche
|
Stable Coronary Heart Disease Patients With Recent
Acute Coronary Syndrome |
| Solvay
|
Acute heart failure patients with
renal dysfunction.
|
| Astellas Pharma Inc. |
A Phase 3b study of Vernakalant Injection in Patients with recent onset symptomatic Atrial Fibrillation
|